HilleVax, Inc.
HLVX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $2,156 | $2,252 | $3 |
| Gross Profit | $0 | -$2,156 | -$2,252 | -$3 |
| % Margin | – | – | – | – |
| R&D Expenses | $78,172 | $106,683 | $45,908 | $10,014 |
| G&A Expenses | $28,787 | $26,662 | $16,705 | $5,756 |
| SG&A Expenses | $28,787 | $26,662 | $16,705 | $5,756 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $48,332 | $0 | -$94,696 | $0 |
| Operating Expenses | $155,291 | $133,345 | $62,613 | $15,770 |
| Operating Income | -$155,291 | -$133,345 | -$65,113 | -$53,426 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $8,024 | $9,779 | -$94,696 | -$48,982 |
| Pre-Tax Income | -$147,267 | -$123,566 | -$159,809 | -$102,408 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$147,267 | -$123,566 | -$257,005 | -$85,025 |
| % Margin | – | – | – | – |
| EPS | -3 | -3.04 | -6.83 | -2.82 |
| % Growth | 1.3% | 55.5% | -142.2% | – |
| EPS Diluted | -3 | -3.04 | -6.83 | -2.82 |
| Weighted Avg Shares Out | 49,153 | 40,598 | 37,656 | 30,191 |
| Weighted Avg Shares Out Dil | 49,153 | 40,598 | 37,656 | 30,191 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7,054 | $9,706 | $3,875 | $3 |
| Interest Expense | -$3,318 | $2,392 | $3,414 | $2,844 |
| Depreciation & Amortization | $0 | $879 | $2,252 | $3 |
| EBITDA | -$155,291 | -$132,466 | -$65,113 | -$99,561 |
| % Margin | – | – | – | – |